Vedolizumab in moderately to severely active ulcerative colitis or Crohn’s disease: a guide to its use Katherine A. Lyseng-Williamson Adis Drug Q&A 24 May 2016 Pages: 265 - 275
Umeclidinium/vilanterol dry-powder inhaler in chronic obstructive pulmonary disease: a guide to its use in the EU Yahiya Y. SyedKatherine A. Lyseng-WilliamsonEmma D. Deeks Adis Drug Q&A 12 May 2016 Pages: 276 - 281
Riluzole oral suspension in amyotrophic lateral sclerosis: a guide to its use Gillian M. Keating Adis Drug Q&A 03 June 2016 Pages: 282 - 286
Manage haematological malignancies during pregnancy according to cancer type and gestational stage Adis Medical Writers Disease Management 04 May 2016 Pages: 287 - 291
First reports of adverse drug reactions Drug Reactions and Interactions 13 June 2016 Pages: 292 - 293
Injectable promethazine: a risky drug of questionable efficacy Miriam CohenFrank StalloneDaniel J. Pallin Editorial 13 April 2016 Pages: 294 - 296
Adverse drug reactions in the oral cavity Gowri SivaramakrishnanKannan Sridharan Review Article 13 May 2016 Pages: 297 - 303
Off-label use and pharmacovigilance among infants: analysis of the Thai Health Product Vigilance National Database Pawalee NiamtawornWimon SuwankesawongNathorn Chaiyakunapruk Original Research Article 04 May 2016 Pages: 304 - 310